Influenza in Taiwan: Seasonality and vaccine strain match

Journal of Microbiology, Immunology and Infection

Volumn 38, Issue 4, 2005, Pages 238-243

  Hsieh, Yu Chia ^a   Chen, Hour Young ^b   Yen, Jer Jea ^b   Liu, Ding Ping ^b   Chang, Luan Yin ^c   Lu, Chun Yi ^c   Shao, Pei Lan ^c   Lee, Chin Yun ^c   Huang, Li Min ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CENTER FOR DISEASE CONTROL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Disease outbreaks; Epidemiology; Influenza; Influenza vaccines; Review

Indexed keywords

INFLUENZA VACCINE;

CHINA; COST CONTROL; EPIDEMIC; HEALTH SURVEY; HUMAN; INFLUENZA; INFLUENZA VIRUS; REVIEW; SEASONAL VARIATION; TAIWAN; VACCINATION; VIRUS STRAIN; WINTER; WORLD HEALTH ORGANIZATION;

HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE; SEASONS; TAIWAN;

EID: 24744471461     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Murphy BR, Webster RG. Orthomyxoviruses. In: Fields BN, Knipe DM, eds. Virology. 2nd ed. New York: Raven Press; 1990:1091-152.
2. Strikas RA, Wallace GS, Myers MG. Influenza pandemic preparedness action plan for the United States: 2002 update. Clin Infect Dis 2002;35:590-6.
3. Monto AS. Individual and community impact of influenza. Pharmacoeconomics 1999;16:1-6.
4. Cox NJ, Subbarao K. Influenza. Lancet 1999;354:1277-82.
5. Carrat F, Valleron AJ. Influenza mortality among the elderly in France, 1980-90: how many deaths may have been avoided through vaccination? J Epidemiol Community Health 1995;49:419-25.
6. Fleming DM, Zambon M, Bartelds AI, de Jong JC. The duration and magnitude of influenza epidemics: a study of surveillance data from sentinel general practices in England, Wales and Netherlands. Eur J Epidemiol 1999;15:467-73.
7. Monto AS, Kioumehr F. The Tecumseh Study of Respiratory Illness. IX. Occurrence of influenza in the community, 1966-1971. Am J Epidemiol 1975;102:553-63.
8. Baker WH. Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78. Am J Public Health 1986;76:761-5.
9. Barker WH, Mullooly JP. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol 1980;112:798-811.
10. Smith W, Andrewes CH, Laidlaw PP. A virus obtained from influenza patients. Lancet 1933;2:66-88.
11. Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918-20 "Spanish" influenza pandemic. Bull Hist Med 2002;76:105-15.
12. Kawaoka Y, Krauss S, Webster RG. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol 1989;63:4603-8.
13. Tseng RK, Chen HY, Hong CB. Influenza virus infection in Taiwan from 1979 to 1995. Jpn J Med Sci Biol 1996;49:77-93.
14. Strokes J, Chenoweth A, Waltz A, Shaw D. Results of immunization by means of active virus of human influenza. J Clin Invest 1937;16:237-43.
15. Nichol KL, Lind A, Margolis KL, Murdoch M, McFadden R, Hauge M, et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 1995;333:889-93.
16. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in the elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995;123:518-27.
17. Fedson DS, Wajda A, Nicol JP, Hammond GW, Kaiser DL, Roos LL. Clinical effectiveness of influenza vaccination in Manitoba. JAMA 1993;270:1956-61.
18. Nichol KL, Wouremna J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 1998;158:1769-76.
19. Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 1999;130:397-403.
20. Nordin J, Mullooly J, Poblete S, Strikas R, Petrucci R, Wei F, et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J Infect Dis 2001;184:665-70.
21. Nichol KL, Mendelman PM, Mallon KP, Jackson LA, Gorse GJ, Belshe RB, et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA 1999;282:137-45.
22. Edwards KM, Dupont WD, Westrich MK, Plummer WD Jr, Palmer PS, Wright PF. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis 1994;169:68-76.
23. de Jong JC, Beyer WER, Palache AM, Rimmelzwaan GF, Osterhaus AD. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. J Med Virol 2000;61:94-9.
24. Ellis E, Weber JM, Cuff W, Mackenzie SG. Influenza vaccine match with circulating strains and indicators of influenza strain impact - Canada 1980 to 1992. Can J Infect Dis Med Microbiol 1998;9:143-8.
25. Cox NJ, Brammer TL, Regnery HL. Influenza: global surveillance for epidemic and pandemic variant. Eur J Epidemiol 1994;10:467-70.
26. Cox NJ, Regnery HL. Global influenza surveillance: tracking a moving target in a rapidly changing world. In: Hampson AW, Webster RG, Brown LE, eds. Options for the control of influenza III, Cairns, Australia. Amsterdam: Elsevier; 1996:591-8.